Dariohealth CORP Form 4 insider transactions

Steven Charles Nelson, Chief Commercial Officer of DarioHealth Corp., received stock options to purchase shares of common stock, according to a recent SEC filing.

DarioHealth Corp. CFO Zvi Ben-David reports acquiring 400,000 shares of common stock and disclaims beneficial ownership of 1,786 shares held by spouse.

Director Yoav Shaked reports acquiring 90,000 shares of DarioHealth Corp. common stock on March 6, 2024.

Richard Anderson, President of DarioHealth Corp., reports the acquisition of stock options in the company.

Jon Kaplan, a director of DarioHealth Corp., acquired 70,000 shares of common stock on March 6, 2024.

Director Hila Karah reports acquiring 70,000 shares of DarioHealth Corp. on March 6, 2024.

DarioHealth Corp. CEO Raphael Erez reports the acquisition of 800,000 shares of common stock and indirect beneficial ownership of 37,876 shares held by Dicilyon Consulting and Investment Ltd.

Director Dennis McGrath acquired 80,000 shares of DarioHealth Corp. common stock on March 6, 2024.

Director Dennis Matheis reports acquiring 70,000 shares of DarioHealth Corp. common stock on March 6, 2024.

Adam Stern, a director at DarioHealth Corp., reported acquiring 70,000 shares and disposing of shares, according to a recent SEC Form 4 filing.

Adam Stern, a director of DarioHealth Corp., reports the acquisition of Series-C Preferred Stock convertible into common stock, along with indirect ownership of common stock through AKS Family Partnership, L.P.